IRAK4 and viral infectious disease: Patients with mutations in downstream components of TLR signaling such as interleukin-1 receptor-associated kinase 4 (IRAK-4) and MyD88 are not susceptible to viral infections such as VZV, highlighting the functional redundancy in the TLR pathogen sensing pathway (80).